4.2 Article

Long term follow-up of scoliosis progression in type II SMA patients

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2) : a phase 3, double-blind, randomised, placebo-controlled trial

Eugenio Mercuri et al.

Summary: Risdiplam has shown significant improvement in motor function compared to placebo in patients with type 2 or non-ambulant type 3 spinal muscular atrophy. Motor function generally improved in younger patients and stabilized in older patients.

LANCET NEUROLOGY (2022)

Article Respiratory System

Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1-3

Archana Chacko et al.

Summary: The first year of nusinersen treatment showed a reduced decline in lung function, especially in type 2 SMA patients, and an improvement in Apnoea-Hypopnoea Index (AHI).

THORAX (2022)

Article Clinical Neurology

Nusinersen treatment of older children and adults with spinal muscular atrophy

Chamindra G. Konersman et al.

Summary: This study aimed to determine the effectiveness of nusinersen in improving motor function in older adolescent and adult patients with spinal muscular atrophy. Results showed that older patients receiving nusinersen treatment experienced improvements in motor function, with stabilized symptoms and incremental progress observed over the study period.

NEUROMUSCULAR DISORDERS (2021)

Review Genetics & Heredity

Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis

Giorgia Coratti et al.

Summary: This review critically examined real-world data on motor function in SMA patients treated with Nusinersen, finding positive changes in the treated group compared to negative changes in the untreated group.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Clinical Neurology

AAN position statement: Ethical issues in clinical research in neurology

Benjamin Tolchin et al.

NEUROLOGY (2020)

Article Genetics & Heredity

Natural history of lung function in spinal muscular atrophy

Camiel A. Wijngaarde et al.

ORPHANET JOURNAL OF RARE DISEASES (2020)

Article Clinical Neurology

Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3

Lorenzo Maggi et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Medicine, General & Internal

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

E. Mercuri et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Clinical Neurology

Prospective cohort study of spinal muscular atrophy types 2 and 3

Petra Kaufmann et al.

NEUROLOGY (2012)

Article Pediatrics

SCOLIOSIS IN SPINAL MUSCULAR ATROPHY: NATURAL HISTORY AND MANAGEMENT

Luciano Merlini et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)

Article Clinical Neurology

Feeding problems and malnutrition in spinal muscular atrophy type II

Sonia Messina et al.

NEUROMUSCULAR DISORDERS (2008)

Article Clinical Neurology

The Hammersmith functional score correlates with the SMN2 copy number:: A multicentric study

F. D. Tiziano et al.

NEUROMUSCULAR DISORDERS (2007)